Home » Topics » Regulatory

Regulatory
RSS

Schering-Plough's Claritin line expanded

Oct. 18, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Improved formulation of Testoderm available in U.S.

Oct. 11, 1996

Muse approvable for treatment of impotence

Oct. 11, 1996

European approvals for Zantac

Oct. 11, 1996

BTG licenses drug for cardiac arrest

Oct. 11, 1996

Approval of Pulmozyme recommended for new indication

Oct. 11, 1996

Treatment for cystic fibrosis patients progresses on schedule

Oct. 11, 1996

New antihistamine for pediatric patients in the U.S.

Oct. 11, 1996

First U.S. launch of product using Scherer's Zydis technology

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...